Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Levy

Showing results (71-80 of 134) with videos related to

Pageof 14
Sort By:
Pharmacogenomics and Personalized Medicine|May 8, 2018
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementationRabea Asleh, Alexandros Briasoulis, Elliot M Berinstein, et al.
Journal of the American College of Cardiology|December 12, 2002
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart StudyAndrew P Levy, Irit Hochberg, Kathleen Jablonski, et al.
Neurosurgery|October 17, 2009
Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhageEric N Momin, Kristin E Schwab, Kaisorn L Chaichana, et al.
Translational Psychiatry|April 23, 2021
Pharmacological modulation of AMPA receptors rescues specific impairments in social behavior associated with the A350V Iqsec2 mutationRenad Jabarin, Nina Levy, Yasmin Abergel, et al.
Journal of Biomolecular Structure & Dynamics|April 20, 2023
Molecular modeling of ARF6 dysregulation caused by mutations in IQSEC2Michael Shokhen, Randall Walikonis, Vladimir N Uversky, et al.
Cardiovascular Diabetology|June 4, 2009
Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic miceRoy Asaf, Shany Blum, Ariel Roguin, et al.
Sleep|September 21, 2005
Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the Sleep Heart Health StudyAndrew P Levy, Lin Zhang, Rachel Miller-Lotan, et al.
Journal of Diabetes and Its Complications|August 20, 2016
Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC)Trevor J Orchard, Jye-Yu C Backlund, Tina Costacou, et al.
Journal of Diabetes Research|September 26, 2018
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and MiceInbal Dahan, Nadia Thawho, Evgeny Farber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 8, 2019
Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery DiseaseRabea Asleh, Andrew P Levy, Nina S Levy, et al.
Pageof 14

Showing results (71-80 of 134) with videos related to

Sort By:
Pageof 14
Pharmacogenomics and Personalized Medicine|May 8, 2018
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementationRabea Asleh, Alexandros Briasoulis, Elliot M Berinstein, et al.
Journal of the American College of Cardiology|December 12, 2002
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart StudyAndrew P Levy, Irit Hochberg, Kathleen Jablonski, et al.
Neurosurgery|October 17, 2009
Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhageEric N Momin, Kristin E Schwab, Kaisorn L Chaichana, et al.
Translational Psychiatry|April 23, 2021
Pharmacological modulation of AMPA receptors rescues specific impairments in social behavior associated with the A350V Iqsec2 mutationRenad Jabarin, Nina Levy, Yasmin Abergel, et al.
Journal of Biomolecular Structure & Dynamics|April 20, 2023
Molecular modeling of ARF6 dysregulation caused by mutations in IQSEC2Michael Shokhen, Randall Walikonis, Vladimir N Uversky, et al.
Cardiovascular Diabetology|June 4, 2009
Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic miceRoy Asaf, Shany Blum, Ariel Roguin, et al.
Sleep|September 21, 2005
Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the Sleep Heart Health StudyAndrew P Levy, Lin Zhang, Rachel Miller-Lotan, et al.
Journal of Diabetes and Its Complications|August 20, 2016
Haptoglobin 2-2 genotype and the risk of coronary artery disease in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC)Trevor J Orchard, Jye-Yu C Backlund, Tina Costacou, et al.
Journal of Diabetes Research|September 26, 2018
The Iron-Klotho-VDR Axis Is a Major Determinant of Proximal Convoluted Tubule Injury in Haptoglobin 2-2 Genotype Diabetic Nephropathy Patients and MiceInbal Dahan, Nadia Thawho, Evgeny Farber, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 8, 2019
Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery DiseaseRabea Asleh, Andrew P Levy, Nina S Levy, et al.
Pageof 14